Literature DB >> 17494720

Comparison of various blood compartments and reporting units for the detection and quantification of Epstein-Barr virus in peripheral blood.

H Hakim1, C Gibson, J Pan, K Srivastava, Z Gu, M J Bankowski, R T Hayden.   

Abstract

Epstein-Barr virus (EBV) infection is associated with a broad spectrum of disease. While quantification of EBV nucleic acid in the peripheral blood has been demonstrated to be useful for diagnosis and patient care, the optimal sample type and reporting format for such testing remain uncertain. Using quantitative real-time PCR (QRT-PCR), we evaluated EBV in whole blood (WB), peripheral blood mononuclear cells (PBMC), and plasma in 249 samples from 122 patients. In WB and PBMC, results were reported both in viral copies/ml and in copies/microg of total DNA. Trendings of quantitative values over time among the different sample types were compared. The sensitivities of QRT-PCR using WB and that using PBMC did not differ significantly (P = 0.33), and both were more sensitive than plasma alone (P < 0.0001). EBV viral load results from WB and PBMC paired sample types also showed a significant correlation (P < 0.05), as did results reported in copies/ml and copies/microg DNA for both WB and PBMC (R2 > 0.93). EBV viral loads detected using WB and PBMC trended very closely for the few patients who had multiple positive samples available for analysis. WB and PBMC show comparable sensitivities and a close quantitative correlation when assayed for EBV by QRT-PCR. The close correlation between copies/ml and copies/microg DNA also suggests that normalization to cell number or genomic DNA in cellular specimens may not be necessary.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17494720      PMCID: PMC1932972          DOI: 10.1128/JCM.02308-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Development of a real-time quantitative assay for detection of Epstein-Barr virus.

Authors:  H G Niesters; J van Esser; E Fries; K C Wolthers; J Cornelissen; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients.

Authors:  N R Krieger; O M Martinez; S M Krams; K Cox; S So; C O Esquivel
Journal:  Liver Transpl       Date:  2000-01       Impact factor: 5.799

3.  Real-time polymerase chain reaction (RQ-PCR) for the monitoring of Epstein-Barr virus (EBV) load in peripheral blood mononuclear cells.

Authors:  H J Wagner; W Jabs; F Smets; M Wessel; L Fischer; G Offner; H Kirchner; P Bucsky
Journal:  Klin Padiatr       Date:  2000 Jul-Aug       Impact factor: 1.349

4.  High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders.

Authors:  F Baldanti; P Grossi; M Furione; L Simoncini; A Sarasini; P Comoli; R Maccario; R Fiocchi; G Gerna
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.

Authors:  Y M Lo; L Y Chan; A T Chan; S F Leung; K W Lo; J Zhang; J C Lee; N M Hjelm; P J Johnson; D P Huang
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

6.  Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders.

Authors:  W J Jabs; H Hennig; M Kittel; K Pethig; F Smets; P Bucsky; H Kirchner; H J Wagner
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

7.  Monitoring of epstein-barr virus DNA load in peripheral blood by quantitative competitive PCR.

Authors:  S J Stevens; M B Vervoort; A J van den Brule; P L Meenhorst; C J Meijer; J M Middeldorp
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

8.  Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children.

Authors:  M Green; J Bueno; D Rowe; G Mazariegos; L Qu; K Abu-Almagd; J Reyes
Journal:  Transplantation       Date:  2000-08-27       Impact factor: 4.939

9.  Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction.

Authors:  H J Wagner; M Wessel; W Jabs; F Smets; L Fischer; G Offner; P Bucsky
Journal:  Transplantation       Date:  2001-09-27       Impact factor: 4.939

10.  Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.

Authors:  S J Stevens; I Pronk; J M Middeldorp
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

View more
  23 in total

1.  Monitoring of Epstein-Barr virus load in patients after allogeneic hematopoietic stem cell transplantation.

Authors:  P Volfova; M Lengerova; J Winterova; Z Racil; D Dvorakova; J Mayer
Journal:  Infection       Date:  2012-04-19       Impact factor: 3.553

Review 2.  Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation.

Authors:  Francesco Pegoraro; Claudio Favre
Journal:  Ann Hematol       Date:  2021-02-06       Impact factor: 3.673

3.  Evaluation of the Epstein-Barr virus R-gene quantification kit in whole blood with different extraction methods and PCR platforms.

Authors:  Samira Fafi-Kremer; Patrice Morand; Come Barranger; Gérard Barguès; Stéphane Magro; Jérôme Bés; Philippe Bourgeois; Martine Joannes; Jean-Marie Seigneurin
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

4.  Comparative evaluation of a commercially available automated system for extraction of viral DNA from whole blood: application to monitoring of epstein-barr virus and cytomegalovirus load.

Authors:  Sylvie Pillet; Thomas Bourlet; Bruno Pozzetto
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

5.  When kissing (disease) counts.

Authors:  Katrien Van Roosbroeck; George A Calin
Journal:  Blood       Date:  2016-04-21       Impact factor: 22.113

Review 6.  Post Transplant Lymphoproliferative Disorder.

Authors:  Devika Gupta; Satish Mendonca; Sushmita Chakraborty; Tathagata Chatterjee
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-17       Impact factor: 0.900

7.  Detection of cytomegalovirus in whole blood using three different real-time PCR chemistries.

Authors:  Erica Vincent; Zhengming Gu; Markus Morgenstern; Candace Gibson; Jianmin Pan; Randall T Hayden
Journal:  J Mol Diagn       Date:  2008-12-12       Impact factor: 5.568

8.  Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus.

Authors:  R T Hayden; K M Hokanson; S B Pounds; M J Bankowski; S W Belzer; J Carr; D Diorio; M S Forman; Y Joshi; D Hillyard; R L Hodinka; M N Nikiforova; C A Romain; J Stevenson; A Valsamakis; H H Balfour
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

9.  Hepatitis C virus RNA quantitation in venous and capillary small-volume whole-blood samples.

Authors:  Tony Bruns; Katrin Steinmetzer; Eugen Ermantraut; Andreas Stallmach
Journal:  J Clin Microbiol       Date:  2009-08-19       Impact factor: 5.948

10.  The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases.

Authors:  Jennifer A Kanakry; Aparna M Hegde; Christine M Durand; Allan B Massie; Amy E Greer; Richard F Ambinder; Alexandra Valsamakis
Journal:  Blood       Date:  2016-01-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.